1. Home
  2. ETON vs LAES Comparison

ETON vs LAES Comparison

Compare ETON & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

N/A

Current Price

$15.96

Market Cap

498.8M

Sector

Health Care

ML Signal

N/A

Logo SEALSQ Corp

LAES

SEALSQ Corp

N/A

Current Price

$3.91

Market Cap

366.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ETON
LAES
Founded
2017
2022
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
498.8M
366.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
LAES
Price
$15.96
$3.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$29.67
$6.00
AVG Volume (30 Days)
282.6K
13.0M
Earning Date
11-06-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,316,000.00
$10,978,000.00
Revenue This Year
$113.27
N/A
Revenue Next Year
$36.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
102.77
N/A
52 Week Low
$11.09
$1.98
52 Week High
$23.00
$11.00

Technical Indicators

Market Signals
Indicator
ETON
LAES
Relative Strength Index (RSI) 41.62 39.56
Support Level $15.75 $4.45
Resistance Level $17.19 $5.09
Average True Range (ATR) 0.73 0.38
MACD 0.05 -0.03
Stochastic Oscillator 35.08 0.00

Price Performance

Historical Comparison
ETON
LAES

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

Share on Social Networks: